|
4-Hydroxy Omeprazole Sulfide
|
4-羥基奧美拉唑硫醚-2-基)甲基]磺?；鵠-1氫-苯并咪唑 (奧美拉唑 砜)
|
103876-98-8
|
|
5-METHOXY-2-[((4-METHOXY-3,5-DIMETHYL-1-OXIDO-2-PYRIDINYL)METHYL)SULFINYL]-BENZIMIDAZOLE
|
4-甲氧基-2-[[（RS）-（5-甲氧基-1H-苯駢咪唑-2-基）亞磺?；鵠甲基]-3，5-二甲基吡啶1-氧化物
|
176219-04-8
|
|
5-METHOXY-2-[(3,5-DIMETHYL-2-PYRIDINYL)-METHYLSULFINYL]-BENZIMIDAZOLE
|
2-[（RS）-[（3，5-二甲基-2-吡啶基）甲基] 亞磺酰基]-5-甲氧基-1H-苯駢咪唑
|
110374-16-8
|
|
Pyridine, 4-chloro-2-(chloromethyl)-3,5-dimethyl-, hydrochloride
|
2-氯甲基 -3.5-二甲基-4-氯-吡啶鹽酸鹽
|
143016-68-6
|
|
(+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride
|
(S)-(o-氯苯基)-6,7-二羥噻吩[3,2-C]吡啶-5(4H)-乙酸鹽酸鹽
|
144750-42-5
|
|
(3R,5S,E)-7-(4-(4-fluorophenyl)-2-((2-hydroxy-N,2-dimethylpropyl)sulfonamido)-6-isopropylpyrimidin-5-yl)-3,5-dihydroxyhept-6-enoic acid sodium salt
|
瑞舒伐他汀鈣EP雜質(zhì)A（鈉鹽）
|
1714147-47-3
|
|
Mirabegron impurity D
|
米拉貝隆雜質(zhì)D
|
|
|
Pentanamide,5-chloro-
|
5-氯戊酰胺
|
2455-05-2
|
|
4-Desmethyl-2-methyl Celecoxib;4-[5-(2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide
|
塞來昔布異構(gòu)體雜質(zhì)
|
170569-99-0
|
|
METHYL 5-FORMYL-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE
|
5-醛基-2, 4-二甲基-1H-吡咯-3-甲酸甲酯
|
58298-68-3
|
|
(1R)-3-(dimethylamino)-1-thiophen-2-ylpropan-1-ol
|
R-（+）-3-(二甲基氨基)-1-(2-噻吩基)-1-丙醇
|
132335-49-0
|
|
2-(4-nitrophenyl)ethyl methyl ether
|
2-(4-硝基苯基)乙基甲醚
|
69628-98-4
|
|
3-(Dimethylamino)-1-(3-thienyl)-1-propanone Hydrochloride
|
3-(二甲基氨基)-1-(3-噻吩基)-1-丙酮鹽酸鹽
|
14994-02-6
|
|
4-(2-methoxyethyl)aniline
|
4-(2-甲氧基乙基)苯胺
|
84803-56-5
|
|
4-[(1S)-3-(Methylamino)-1-(2-thienyl)propoxy]-1-naphthaleno
|
4-[(1S)-3-(甲基氨基)-1-(2-噻吩基)丙基]-1-萘酚
|
662149-13-5
|
|
Mixture of N-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole and N'-(4-Methoxy-3,5-dimethyl-2-pyridinyl)methyl Omeprazole
|
N-(4-甲氧基-3,5-二甲基-2-吡啶)甲基 奧美拉唑 和 N’-(4-甲氧基-3,5-二甲基-2-吡啶)甲基 奧美拉唑
|
1346599-85-6
|
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-1-amine Oxalate
|
鹽酸度洛西汀EP雜質(zhì)F
|
116817-28-8
|
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-2-amine
|
鹽酸度洛西汀EP雜質(zhì)F
|
1104890-90-5
|
|
N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-3-yl)propan-3-amine HCl
|
鹽酸度洛西汀EP雜質(zhì)F
|
116817-27-7
|
|
R-DULOXETINE Oxalate
|
R-度洛西汀草酸鹽
|
116539-60-7
|
|
5-(4-Bromophenyl)-4,6-dichloropyrimidine
|
5-(4-溴苯基)-4;馬西替坦中間體2(5-(4-溴苯基)-4,6-二氯嘧
|
146533-41-7
|
|
Sitagliptin Fumarate Adduct(Sitagliptin Impurity FP-A)
|
西他列汀富馬酸加成物
|
2088771-60-0
|
|
3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL
|
2-氯甲基 -3.5-二甲基-吡啶鹽酸鹽
|
73590-93-9
|
|
(E)-5-(2, 5-dimethyl-4-(prop-1-enyl)phenoxy)-2, 2-dimethylpentanoic acid
|
吉非羅齊USP雜質(zhì)A
|
500904-61-0
|
|
(S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)aMino)-3- Methylbutanoic acid
|
N-[[2'(-(1H-四唑-5-基)[1,1'(-聯(lián)苯]-4-基]甲基]-L-纈氨酸
|
676129-92-3
|
|
1-chloro-3-(propan-2-ylamino)propan-2-ol,hydrochloride
|
1-氯-3-異丙基氨基-2-丙醇鹽酸鹽
|
39552-14-2
|
|
1-Chloro-3-isopropylamino-2-propanol
|
1-氯-3-異丙基氨基-2-丙醇，
|
50666-68-7
|
|
3-Morpholinone, 4-(2-aMinophenyl)-
|
3-嗎啉酮,4-(2-氨基苯基)
|
1082588-73-5
|
|
4-Butoxybutyl alcohol
|
4-丁氧基丁醇
|
4161-24-4
|
|
Atorvastatin EP IMpurity A
|
阿托伐他汀EP雜質(zhì)A
|
433289-83-9
|
|
Atorvastatin EP IMpurity C
|
阿托伐他汀鈣雜質(zhì)C
|
693793-53-2
|
|
Defluoro Atorvastatin Acetonide tert-Butyl Ester
|
ATO-10脫氟雜質(zhì)
|
1105067-91-1
|
|
Difluoro Atorvastatin Acetonide tert-Butyl Ester
|
ATO-10雙氟雜質(zhì)
|
693793-87-2
|
|
methyl (-)-(R)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate, hydrogen sulfate
|
氯吡格雷雜質(zhì)C
|
120202-71-3
|
|
Methyl(+/-)-(o-chlorophenyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-acetate, hydrochloride
|
(甲基(+/-)-(O-氯苯基)-4,5-二氫噻吩[2,3-C]吡啶-6(7H)-乙酸酯鹽酸鹽
|
144750-52-7
|
|
Metoprolol EP IMpurity M
|
美托洛爾EP雜質(zhì)M
|
343785-33-1
|
|
N-[4-(4-Fluorophenyl)-6-(1-methylethyl)-5-[(1E)-2-[(2S,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethenyl]-2-pyrimidinyl]-N-methylmethanesulfonamide
|
瑞舒伐他汀EP雜質(zhì)D
|
503610-43-3
|
|
Rosuvastatin Calcium Impurity C (EP)
|
瑞舒伐他汀EP雜質(zhì)C
|
1422619-13-3
|
|
Rosuvastatin EP impurity B
|
瑞舒伐他汀鈣EP雜質(zhì)B（鈉鹽）
|
|
|
(S)-3-[1-(methylamino)ethyl]-phenyl N-ethyl-N-methyl-carbamate
|
卡巴拉汀脫甲基
|
923035-05-6
|
|
4,7-Methano-1H-isoindole-1,3(2H)-dione,2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-methyl]cyclohexyl]
methyl]hexahydro-,(3aR,4R,7S,7aS)
|
魯拉西酮異構(gòu)體
|
1318074-25-7
|
|
4-Desmethoxy-4-chloro Omeprazole Sulfide
|
2-[（RS）-[（4氯-3，5-二甲基-2-吡啶基）甲基] 硫基]-5-甲氧基-1H-苯駢咪唑
|
220757-74-4
|
|
5-(2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl)-7a-hydroxy-5,6,7,7a-tetrahydrothieno[3,2-c]pyridin-2(4H)-one
|
普拉格雷羥基雜質(zhì)
|
947502-66-1
|
|
Omeprazole Sulfone N-Oxide
|
4-甲氧基-2-[[（5-甲氧基-1H-苯駢咪唑-2-基）磺?；鵠甲基]-3，5-二甲基吡啶1-氧化物
|
158812-85-2
|
|
Pentanoyl chloride, 5-chloro-4-methyl-
|
5-氯，4-甲基戊酰氯
|
813452-05-0
|
|
Rosuvastatin EP IMpurity E Calcium Salt
|
瑞舒伐他汀鈣EP雜質(zhì)E（鈣鹽）
|
|
|
5-chlorohexanoyl chloride
|
5-氯己酰氯
|
99585-01-0
|
|
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol
|
(2R,3S/2S,3R)-2-(2,4-二氟苯基)-3-(5-氟嘧啶-4-基)-1-(1H-1,2,4-三唑- 1-基)-2-丁醇
|
182230-43-9
|
|
(S)-4-Desmethoxy-4-chloro Omeprazole
|
2-[（RS）-[（4氯-3，5-二甲基-2-吡啶基）甲基] 亞磺?；鵠-5-甲氧基-1H-苯駢咪唑
|
863029-89-4
|
|
(S)-Sitagliptin Phosphate
|
S-西他列汀磷酸鹽
|
823817-58-9
|
|
1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide
|
阿哌沙班雜質(zhì)2
|
2098457-92-0
|
|
rac-α-[2-(Dimethylamino)ethyl]-3-thiophenemethanol
|
N,N-二甲基-3-羥基-3-(2-噻吩基)丙胺
|
116817-84-6
|
|
2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid
|
2-(2-(2-(2-氨基噻唑-4-基)乙酰氨基)噻唑-4-基)乙酸
|
2036283-13-1
|
|
3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt(Atorvastatin EP IMpurity A)
|
阿托伐他汀鈣雜質(zhì)USP雜質(zhì)B
|
887196-25-0
|
|
2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole
|
2-[（RS）-[（3，5-二甲基-2-吡啶基）甲基]硫基]-5-甲氧基-1H-苯駢咪唑
|
704910-89-4
|
|
4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
|
阿哌沙班雜質(zhì)1
|
1686149-74-5
|